Jan 6, 2017 Roth Capital Partners appoints Michael Margolis, R.Ph. as Head of Healthcare Investment Banking Roth Capital Partners
Jan 5, 2017 Roth Capital Partners Acts as Sole Book-Running Manager for SenesTech, Inc. (NASDAQ: SNES) in its $15 Million IPO Roth Capital Partners
Jan 5, 2017 Roth Capital Partners Acts as Sole Book-Running Manager and Sole Placement Agent For RedHill Biopharma Ltd. (RDHL) in its concurrent $24.4 Million Follow-On and $15 Million Registered Direct Roth Capital Partners
Jan 5, 2017 Roth Capital Partners Acts as Lead U.S. Placement Agent for Pharming Group N.V. (EURONEXT: PHARM) in its €104 Million Financing Roth Capital Partners
Jan 4, 2017 Roth Capital Partners Acts as Sole Book-Running Manager for BioPharmX Corporation (NYSE:BPMX) in its $13 Million Follow-On Roth Capital Partners
Dec 27, 2016 Roth Capital Partners Acts as Sole Book-Running Manager for LightPath Technologies, Inc. (NASDAQ:LPTH) in a $9.7 Million Follow-On and renders a Fairness Opinion in connection with the acquisition of ISP Optics Roth Capital Partners
Dec 5, 2016 Roth Capital Partners Acts as Sole Manager for Cherokee Inc. (CHKE) in its $40 Million Follow-On Roth Capital Partners
Nov 29, 2016 Roth Capital Partners to Host New Industrials Corporate Access Day in New York City on December 13, 2016 Business Wire
